Navigation Links
Veran Medical Technologies Welcomes New Member to its Board of Directors
Date:11/18/2013

ST. LOUIS, Nov. 18, 2013 /PRNewswire/ -- Veran Medical Technologies announced today that Curt Hartman, former Chief Financial Officer at Stryker Corporation, was appointed to the company's Board of Directors.

(Photo: http://photos.prnewswire.com/prnh/20131118/PH19057

"Curt has extraordinary medical device leadership experience, as well as a strategic and entrepreneurial mindset that has consistently delivered market leading results. We are delighted that he is joining Veran's Board of Directors," said Jason Pesterfield, Veran's president and chief executive officer. "We are excited to attract the caliber of expertise that Curt Hartman brings to the table and view this as a strong indication of the potential for Veran's success now and in the future."

Mr. Hartman is currently a member of the Board of Directors of Devicor Medical Products, a global medical products company located in Cincinnati, Ohio. Previously, Mr. Hartman held a number of positions of increasing responsibility during a 22-year career with Stryker Corporation. During his tenure he spent four years as the chief financial officer for the $8.7 billion company, preceded by nine years as President of the Stryker Instruments Division. Prior to joining Stryker he served in the United States Army as a helicopter pilot.

"I am excited to join Veran Medical Technologies and work with this exceptional team and board," Mr. Hartman said. "Veran is emerging as the leader in electromagnetic navigation at a time when lung cancer screening is being recommended for early diagnosis. I look forward to sharing my experiences and contributing to the direction and growth of this dynamic organization."

Mr. Hartman received a Bachelor of Science in Aerospace Engineering from the University of Michigan, and completed the Advanced Management Program at Harvard.

In addition to Curt Hartman, Veran's Board of Directors consists of Gregory R. Johnson (chairman), David Adair, M.D., Bob Paulson, Jason Pesterfield and Ajit Shah.

About Veran Medical Technologies. Veran Medical Technologies is a privately held soft tissue navigation company focused on the early diagnosis of cancer.  Multiple specialties use Veran's electromagnetic navigation platform to enhance hospital oncology programs.  The technology is used to assist with lung, kidney and liver procedures endobronchially or percutaneously for biopsies, ablations, drainages and more.   Veran Medical Technologies is headquartered in St. Louis, MO.

Veran Medical Technologies Media Contact
Michelle Berkley, Marketing Manager | 314.659.8500 | www.veranmedical.com

Read more news from Veran Medical Technologies.


'/>"/>
SOURCE Veran Medical Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CVBT-Aktionäre stimmen für Veränderungen
2. Astute Medical, Inc., veranstaltet Symposium aus anlaß des Critical Care Nephrology Kongress
3. CIOs von GlaxoSmithKline und British American Tobacco als Referenten auf führender Strategie-Veranstaltung für Unternehmensmobilität
4. Marken richtet branchenspezifische Diskussionsveranstaltung in Mexiko-Stadt aus
5. Noverant Launches Major Learning Management System Upgrade
6. China Medical Display Industry Report 2013
7. Varian Medical Systems Board of Directors Authorizes Repurchase of Additional 6 Million Shares of Stock through Calendar Year 2014
8. New Factors Reshaping Medical Education Programs in the Life Sciences Industries
9. Skyline Medical Announces Results for Third Quarter and First Nine Months of 2013
10. Pre-Owned Medical Devices Market is Expected to Reach USD 4.9 Billion Globally in 2019: Transparency Market Research
11. Vasomedical Recorded 33% Year-over-year Growth in Revenue for the Third Quarter of 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):